[An analysis of sclerodermatous graft-versus-host-disease after allogeneic bone marrow transplantation: CD8+CD57+T-cell proliferation and increased production of TGF-beta].
A 19-year-old woman with acute lymphoblastic leukemia received an allogeneic bone marrow transplantation (BMT) from an HLA-identical sibling during the second remission, on September 28, 1993. The conditioning regimen consisted of total body irradiation and cyclophosphamide. Short term methotrexate and cyclosporin A were given for prophylaxis of graft-versus-host disease (GVHD). On day 771 after BMT, she complained of bilateral forearm pain, and developed sclerotic lesions on the skin of the abdominal wall, forearms and legs. The diagnosis of sclerodermatous GVHD was established by skin biopsy on day 834. The values of CRP and IgG were elevated, and both antinuclear antibody and anti-DNA antibody became positive. Flow cytometric analysis showed a significant increase in the number of CD57+ cells after appearance of sclerotic change. In addition, 65% of CD8+ cells were positive for CD57. Circulating level of transforming growth factor (TGF)-beta 1 was high. These results suggest that overproduction of CD8+ CD57+ T cells and high level of circulating TGF-beta are related to the development of sclerodermatous GVHD.
Nakazawa
Y
Y
Department of Pediatrics, Shinshu University School of Medicine, Matsumoto, Japan.
Koike
K
K
Kitazawa
Y
Y
Sakashita
K
K
Sawai
N
N
Matsumoto
K
K
Ito
S
S
Kumagai
T
T
Yamada
M
M
Komiyama
A
A
D000328:Adult; D016026:Bone Marrow Transplantation / Q000009:adverse effects*; D018959:CD57 Antigens / Q000032:analysis*; D018414:CD8-Positive T-Lymphocytes / Q000473:pathology*; D002455:Cell Division; D005260:Female; D006086:Graft vs Host Disease / Q000473:pathology*; D006801:Humans; D054198:Precursor Cell Lymphoblastic Leukemia-Lymphoma / Q000628:therapy*; D012595:Scleroderma, Systemic / Q000209:etiology*; D016212:Transforming Growth Factor beta / Q000096:biosynthesis*; D014184:Transplantation, Homologous
D018959:CD57 Antigens; D016212:Transforming Growth Factor beta